vs
Eos Energy Enterprises, Inc.（EOSE）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Eos Energy Enterprises, Inc.的1.3倍（$75.5M vs $58.0M），Eos Energy Enterprises, Inc.同比增速更快（699.6% vs 27.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-75.2M）
Eos Energy Enterprises是一家专注于锌基长时储能电池技术研发、生产与商业化部署的企业，为公用事业、工商业、微电网等客户提供安全环保的储能解决方案，服务覆盖多区域市场，助力可再生能源消纳与电网稳定运行。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
EOSE vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.3倍
$58.0M
营收增速更快
EOSE
高出671.9%
27.7%
自由现金流更多
PBYI
多$89.6M
$-75.2M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $58.0M | $75.5M |
| 净利润 | $-120.5M | — |
| 毛利率 | -93.8% | 69.3% |
| 营业利润率 | -140.1% | 22.7% |
| 净利率 | -207.7% | — |
| 营收同比 | 699.6% | 27.7% |
| 净利润同比 | 55.1% | — |
| 每股收益（稀释后） | $-0.53 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EOSEPBYI
| Q4 25 | $58.0M | $75.5M | ||
| Q3 25 | $30.5M | $54.5M | ||
| Q2 25 | $15.2M | $52.4M | ||
| Q1 25 | $10.5M | $46.0M | ||
| Q4 24 | $7.3M | $59.1M | ||
| Q3 24 | — | $80.5M | ||
| Q2 24 | — | $47.1M | ||
| Q1 24 | — | $43.8M |
净利润EOSEPBYI
| Q4 25 | $-120.5M | — | ||
| Q3 25 | $-641.4M | $8.8M | ||
| Q2 25 | $-222.9M | $5.9M | ||
| Q1 25 | $15.1M | $3.0M | ||
| Q4 24 | $-268.1M | — | ||
| Q3 24 | — | $20.3M | ||
| Q2 24 | — | $-4.5M | ||
| Q1 24 | — | $-4.8M |
毛利率EOSEPBYI
| Q4 25 | -93.8% | 69.3% | ||
| Q3 25 | -111.2% | 77.7% | ||
| Q2 25 | -203.2% | 76.5% | ||
| Q1 25 | -234.7% | 77.1% | ||
| Q4 24 | -324.0% | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率EOSEPBYI
| Q4 25 | -140.1% | 22.7% | ||
| Q3 25 | -200.6% | 17.6% | ||
| Q2 25 | -419.1% | 12.7% | ||
| Q1 25 | -506.2% | 8.7% | ||
| Q4 24 | -712.8% | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -5.3% |
净利率EOSEPBYI
| Q4 25 | -207.7% | — | ||
| Q3 25 | -2102.1% | 16.2% | ||
| Q2 25 | -1463.2% | 11.2% | ||
| Q1 25 | 144.7% | 6.5% | ||
| Q4 24 | -3696.7% | — | ||
| Q3 24 | — | 25.2% | ||
| Q2 24 | — | -9.6% | ||
| Q1 24 | — | -11.0% |
每股收益（稀释后）EOSEPBYI
| Q4 25 | $-0.53 | $0.26 | ||
| Q3 25 | $-4.91 | $0.17 | ||
| Q2 25 | $-1.05 | $0.12 | ||
| Q1 25 | $-0.20 | $0.06 | ||
| Q4 24 | $-2.30 | $0.40 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $568.0M | $97.5M |
| 总债务越低越好 | $813.3M | $22.7M |
| 股东权益账面价值 | $-2.2B | $130.3M |
| 总资产 | $885.2M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资EOSEPBYI
| Q4 25 | $568.0M | $97.5M | ||
| Q3 25 | $58.7M | $94.4M | ||
| Q2 25 | $120.2M | $96.0M | ||
| Q1 25 | $82.6M | $93.2M | ||
| Q4 24 | $74.3M | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务EOSEPBYI
| Q4 25 | $813.3M | $22.7M | ||
| Q3 25 | $448.5M | $34.0M | ||
| Q2 25 | $445.3M | $45.3M | ||
| Q1 25 | $325.5M | $56.7M | ||
| Q4 24 | $316.9M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益EOSEPBYI
| Q4 25 | $-2.2B | $130.3M | ||
| Q3 25 | $-2.3B | $115.3M | ||
| Q2 25 | $-1.1B | $104.7M | ||
| Q1 25 | $-942.2M | $97.1M | ||
| Q4 24 | $-1.1B | $92.1M | ||
| Q3 24 | — | $71.1M | ||
| Q2 24 | — | $48.5M | ||
| Q1 24 | — | $51.0M |
总资产EOSEPBYI
| Q4 25 | $885.2M | $216.3M | ||
| Q3 25 | $328.2M | $202.9M | ||
| Q2 25 | $361.0M | $194.9M | ||
| Q1 25 | $263.3M | $196.2M | ||
| Q4 24 | $260.3M | $213.3M | ||
| Q3 24 | — | $220.7M | ||
| Q2 24 | — | $205.0M | ||
| Q1 24 | — | $214.1M |
负债/权益比EOSEPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-50.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-75.2M | $14.4M |
| 自由现金流率自由现金流/营收 | -129.7% | 19.1% |
| 资本支出强度资本支出/营收 | 43.1% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-265.0M | $41.7M |
8季度趋势，按日历期对齐
经营现金流EOSEPBYI
| Q4 25 | $-50.3M | $14.4M | ||
| Q3 25 | $-65.9M | $9.7M | ||
| Q2 25 | $-66.1M | $14.1M | ||
| Q1 25 | $-28.9M | $3.6M | ||
| Q4 24 | $-42.7M | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | $11.2M |
自由现金流EOSEPBYI
| Q4 25 | $-75.2M | $14.4M | ||
| Q3 25 | $-82.7M | $9.7M | ||
| Q2 25 | $-73.2M | $14.1M | ||
| Q1 25 | $-33.8M | $3.6M | ||
| Q4 24 | $-55.8M | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率EOSEPBYI
| Q4 25 | -129.7% | 19.1% | ||
| Q3 25 | -271.1% | 17.7% | ||
| Q2 25 | -480.2% | 26.8% | ||
| Q1 25 | -323.6% | 7.7% | ||
| Q4 24 | -769.1% | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度EOSEPBYI
| Q4 25 | 43.1% | 0.0% | ||
| Q3 25 | 55.2% | 0.0% | ||
| Q2 25 | 46.2% | 0.0% | ||
| Q1 25 | 47.0% | 0.1% | ||
| Q4 24 | 180.6% | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率EOSEPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | -1.91× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
